Myriad Genetics buy Guggenheim
Start price
14.12.23
/
50%
€19.70
Target price
14.12.24
€21.01
Performance (%)
20.81%
Price
14.05.24
€23.40
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 20.81%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | 27.869% | 27.869% |
iShares Core DAX® | 1.662% | 4.835% |
iShares Nasdaq 100 | 0.667% | 0.000% |
iShares Nikkei 225® | -2.139% | -4.786% |
iShares S&P 500 | 0.564% | 0.775% |
Comments by Guggenheim for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat